Molina Healthcare, Inc. (MOH) fair value analysis
S&P 500 · Updated 2026-10-19
MOH price how computed
Forward Fair Value verdict
OvervaluedMOH is trading at more than a 25% premium to estimated fair value.
Based on TickrTrends' weekly Forward Fair Value model.
- Last price
- $180.85
- Sector
- Healthcare
- 12-month range
- $122.65–$242.88
- Market cap
- $9.28B
- From 52-week high
- -25.5%
- Shares outstanding
- 51.3M
- Rank in Healthcare by discount to fair value
- #88 of 108
Last price is the 2026-10-01 month-start close, the freshest stored price; the chart runs through 2026-09-11.
Molina Healthcare, Inc. is a managed care company that provides health insurance coverage and healthcare services to individuals eligible for government-sponsored programs such as Medicaid and Medicare. The company operates managed care plans across multiple states in the United States, serving low-income families, elderly individuals, and people with disabilities.
MOH currently ranks #88 of 108 Healthcare stocks by discount to fair value. It has screened as Overvalued for 14 consecutive weekly runs.
Fundamentals (4 quarters) how computed
- Market cap
- $9.28B
- P/E (trailing)
- 61x
- Revenue (TTM)
- $44.5B
- Net margin
- -0.0%
- EPS (TTM)
- $2.95
- Gross margin
- 100.0%
- Debt / equity
- 0.95
- Revenue growth (3-yr avg)
- 9.1%
- Shares outstanding
- 51.3M
Derived indicators how computed
- Quality grade
- F
- Margin trend
- Expanding
- 52-week position
- The lower-middle quarter of its range
Technicals how computed
- RSI (14-day)
- 51 · neutral
- 50-day average
- $208.29
- 200-day average
- $178.58
- Moving-average state
- 50-day above 200-day (golden cross state); price between the averages
What our data shows for MOH
- Our model validated 17 trailing price-to-earnings windows for MOH, built from quarterly earnings records.
- Shares are trading in the middle of their 12-month price range of $122.65–$242.88.
- The 14-day relative strength index sits at a neutral 51.
The exact numbers are one step away
- The precise Forward Fair Value dollar figure for MOH
- Exact discount / premium to today's price
- The normalized historical P/E behind the estimate, and how many quarters support it
- Forward EPS input and fiscal-year basis
- Screeners and rankings across the full S&P 500 and Nasdaq universes
Forward Fair Value applies a conservatively normalized historical price-to-earnings multiple to the consensus earnings estimate for the next full fiscal year; how TickrTrends computes it.
Recent MOH news
TickrTrends' derived news-sentiment signal for MOH is currently leaning positive, computed from recent coverage.
- Molina Healthcare (MOH) Shares Dip After Q3 Beat Despite Strong Revenue Growth (gurufocus.com, 2026-10-21)
TickrTrends take: Molina Healthcare delivered better-than-expected third quarter results with robust revenue expansion, yet the market's negative reaction to the shares suggests investors may be reassessing growth sustainability or profitability metrics relative to the stock's current price. Given TickrTrends' overvalued designation for MOH, the post-earnings decline could reflect the market beginning to price in more conservative assumptions about the healthcare company's future performance. Valuation-focused investors should monitor whether management's fourth quarter guidance and margin trends justify the current trading level or whether further downside pressure may be warranted. - Is Molina Healthcare (MOH) Undervalued Despite Q3 Earnings Beat? EPS at $0.73 and Revenue of $11.08 Billion; GF Score: 80/100 (gurufocus.com, 2026-10-21)
TickrTrends take: MOH reported third quarter earnings per share and revenue that exceeded expectations, yet TickrTrends currently assesses the stock as overvalued within the Healthcare sector. The disconnect between strong operational performance and the overvaluation verdict suggests investors should monitor whether the company's earnings trajectory can justify current price levels, or whether market pricing has moved ahead of fundamental improvements. For valuation-focused readers, the key observation is that positive earnings surprises alone may not resolve concerns about whether the stock is trading at a sustainable multiple relative to its sector peers and growth prospects. - A Look at Molina Healthcare Inc (MOH) After 4.5% Gain -- GF Value $380.15 vs Price $219.72 (gurufocus.com, 2026-10-20)
TickrTrends take: Molina Healthcare trades significantly below its GuruFocus estimated fair value, suggesting a meaningful gap between the market's current pricing and fundamental valuation metrics. Despite TickrTrends' overvalued designation, this particular valuation model points to potential upside if the company's underlying business performance supports the higher estimate. Investors focused on valuation should monitor whether MOH's operational results and sector dynamics narrow this gap or whether the market price reflects risks the GF Value calculation may not fully capture.
More MOH news
- Is It Too Late to Buy Molina Healthcare Inc (MOH) After 3.8% Rally? GF Value Says Undervalued (gurufocus.com, 2026-10-12)
- Molina Healthcare Inc (MOH) Stock Down 4.4% -- Now Undervalued? GF Score: 81/100 (gurufocus.com, 2026-10-01)
- Molina Healthcare Inc (MOH) Stock Down 3.3% -- Now Undervalued? GF Score: 82/100 (gurufocus.com, 2026-09-22)
What people are saying
Follow the MOH conversation: Stocktwits · Reddit · X
TickrTrends weekly updates
- 2026-10-19 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-12 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-11 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-10 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-06 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-28 — TickrTrends' derived indicators for MOH showed a change this week in the DCF cross-check band, which shifted from an overvalued assessment to none. The current valuation verdict remains overvalued.
- 2026-09-21 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-17 — No material change this week: the verdict, bands and grades all held steady.
Frequently asked questions
Is MOH stock undervalued?
Based on TickrTrends' Forward Fair Value model (updated 2026-10-19), MOH is trading at more than a 25% premium to estimated fair value and screens as overvalued. The exact fair value and discount are available to subscribers.
What is MOH's TickrTrends verdict?
MOH's current verdict is Overvalued, refreshed with every weekly Forward Fair Value run.
How does MOH compare to other Healthcare stocks?
MOH ranks #88 of 108 Healthcare stocks in TickrTrends' coverage by discount to fair value.
Is MOH overbought or oversold?
MOH's 14-day RSI is in neutral territory - neither overbought nor oversold.
More in Healthcare
Head-to-head comparisons
MOH vs ALKS · MOH vs ANGO · MOH vs CDNA · MOH vs CRL · MOH vs FDMT